作者
Donna L Mendrick, Anna Mae Diehl, Lisa S Topor, Rodney R Dietert, Yvonne Will, Michele A La Merrill, Sebastien Bouret, Vijayalaskshmi Varma, Kenneth L Hastings, Thaddeus T Schug, Susan G Emeigh Hart, Florence G Burleson
发表日期
2018/3/1
来源
Toxicological Sciences
卷号
162
期号
1
页码范围
36-42
出版商
Oxford University Press
简介
Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic, a Society of Toxicology Contemporary Concepts in Toxicology (CCT) workshop was held on March 11, 2017. The meeting was convened to raise awareness of metabolic syndrome and its associated diseases and serve as a melting pot with scientists of multiple disciplines (eg, toxicologists, clinicians, regulators) so as to spur research and understanding of this condition. The criteria for metabolic syndrome include obesity, dyslipidemia (low high-density lipoprotein and/or elevated triglycerides), elevated blood pressure, and alterations in glucose metabolism. It can lead to a greater potential of type 2 diabetes, lipid disorders, cardiovascular disease, hepatic steatosis, and other circulatory disorders. Although there are no approved drugs specifically for this syndrome, many drugs target diseases associated with this syndrome thus …
引用总数
2017201820192020202120222023202415284960535240
学术搜索中的文章
DL Mendrick, AM Diehl, LS Topor, RR Dietert, Y Will… - Toxicological Sciences, 2018